Skip to main content

Heparin News

ASCO: Direct Oral Anticoagulant Therapy Feasible for Cancer Patients

TUESDAY, June 6, 2023 – Direct oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients,...

FDA Medwatch Alert: SCA Pharmaceuticals (SCA) Is Issuing a Voluntary Nationwide Recall of Heparin Sodium Compounded Products Due to Incorrect Preservative (Benzyl Alcohol)

August 18, 2020 – Windsor, CT, SCA Pharmaceuticals (SCA) is voluntarily recalling 10 lots of Heparin Sodium to the hospital/user level. The compounded Heparin Sodium bag contains the undeclared...

FDA Medwatch Alert: Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), In 0.9 percent Sodium Chloride Injection, 500 mL by Hospira: Recall - Particulate Matter

ISSUE: Hospira, Inc. announced a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500...

FDA Medwatch Alert: Heparin: Drug Safety Communication - Important change to heparin container labels to clearly state the total drug strength

ISSUE: FDA is notifying health care professionals, caregivers, and patients about a change to the container and carton labels for heparin products. This label change will require manufacturers of...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Deep Vein Thrombosis (DVT), Deep Vein Thrombosis, Angina, Deep Vein Thrombosis - Prophylaxis, Myocardial Infarction, Heart Attack, Pulmonary Embolism

Heparin patient information at Drugs.com